Xphozah 30 Mg Tablet, Film Coated
Product Images NDC 73154-130

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Xphozah 30 Mg (NDC 73154-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ardelyx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Xphozah 01)

XPHOZAH 20 mg film-coated tablets, oral prescription drug by Ardelyx, Inc. The bottle label displays the product name, strength, dosage form, and the labeler’s name. The packaging is primarily white with green and black text and contains bottle quantity information.*

FDA Label Image

Image (Xphozah 02)

XPHOZAH 20 mg film-coated tablets package label showing proprietary name XPHOZAH and generic name Tenapanor. The label indicates the strength of 20 mg per tablet and the oral route of administration. The labeler is Ardelyx, Inc. The image depicts the drug's packaging with visible branding and dosage information.*

FDA Label Image

Image (Xphozah 03)

XPHOZAH 20 mg film-coated tablets packaging for oral use, labeled with the proprietary name and strength. The box is white with green and dark blue accents, and the labeler is Ardelyx, Inc. The carton design shows the product name prominently with dosing and form information visible on the front panel.*

FDA Label Image

Chemical Structure (Xphozah 04)

Chemical structure diagram of Tenapanor, the active ingredient in XPHOZAH 20 mg oral film-coated tablets by Ardelyx, Inc. The structure shows detailed molecular connectivity including sulfonamide, ureido, and chlorinated aromatic groups.*

FDA Label Image

Image (Xphozah 05)

XPHOZAH 20 mg film-coated oral tablets packaging by Ardelyx, Inc. The label shows the proprietary name XPHOZAH with the active ingredient Tenapanor, indicating the 20 mg strength. The package is designed for prescription use and contains film-coated tablets.*

FDA Label Image

Image (Xphozah 06)

XPHOZAH 20 mg film-coated tablets packaging carton showing the proprietary name prominently. The label indicates Tenapanor as the active ingredient, with a strength of 20 mg per tablet. The product is for oral use and manufactured by Ardelyx, Inc. The carton includes instruction text and regulatory information on side panels.*

FDA Label Image

Image (Xphozah 07)

XPHOZAH 20 mg film-coated tablets packaging with label showing the brand name, strength, and labeled by Ardelyx, Inc. The carton is white with green and black text highlighting the product name and dosage form. The image shows a prescription medication intended for oral use.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Label for XPHOZAH 10 mg tablets, film-coated oral tablets containing tenapanor, distributed by Ardelyx, Inc. The label indicates a package size of 14 tablets and includes storage instructions and NDC 73154-110-14. It advises to store in original container with desiccant to protect from moisture.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Label for XPHOZAH 10 mg tablets containing tenapanor, a human prescription drug by Ardelyx, Inc. The label indicates 60 film-coated oral tablets per container and includes storage instructions, dosage information reference, and manufacturer details. The NDC number and barcode are displayed along with warnings to keep out of reach of children.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Label for XPHOZAH 10 mg film-coated tablets containing tenapanor. The label indicates this is a professional sample with 14 tablets. It includes storage instructions, dosage caution, distributor Ardelyx, Inc., and a barcode. The tablet strength and container information are clearly displayed.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Label for XPHOZAH 20 mg film-coated tablets containing tenapanor, presented in a container of 14 tablets. The label includes storage instructions, distributor information (Ardelyx, Inc., Waltham, MA), and a reminder to keep the product out of reach of children. The NDC code 73154-120-14 is visible along with barcodes and a patent website address.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Label for XPHOZAH 20 mg tablets containing tenapanor, film-coated oral tablets. The label states the product contains 60 tablets, includes storage instructions to keep in original container with desiccant, and is distributed by Ardelyx, Inc. The label also notes a NDC of 73154-120-60 and provides dosage and safety information.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

XPHOZAH 20 mg (tenapanor) film-coated tablets professional sample label. The label indicates 14 tablets for oral use. It includes storage instructions to keep the product at 20°C to 25°C and to store in the original container with a desiccant. Distributed by Ardelyx, Inc., Waltham, MA. The label also notes the product is Rx Only and not for sale.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Label for XPHOZAH 30 mg film-coated tablets containing tenapanor, distributed by Ardelyx, Inc. The label includes dosage storage instructions, barcode, NDC 73154-130-14, and packaging information indicating 14 tablets per container.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Label for XPHOZAH 30 mg (tenapanor) tablets, film-coated oral tablets. The label states the product contains 60 tablets and is for prescription use only. Distributed by Ardelyx, Inc. The label includes storage instructions, dosage equivalence, and a barcode. The design features the brand name in green with the strength highlighted in a green box.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Label for XPHOZAH 30 mg tablets (tenapanor) from Ardelyx, Inc. This professional sample is not for sale and contains 14 film-coated tablets. The label includes storage instructions, dosage recommendation reference, and distributor information. The NDC number is 73154-130-99.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.